Publication | Closed Access
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
108
Citations
23
References
2016
Year
AsthmaAllergyUncontrolled Allergic AsthmaAllergy MedicineMedicinePharmacologyPhase Ii StudyPulmonary PharmacologyPharmacotherapyDrug AllergyClinical Allergy
| Year | Citations | |
|---|---|---|
Page 1
Page 1